Patient-derived xenograft (PDX) tumors increase growth rate with time

Oncotarget. 2016 Feb 16;7(7):7993-8005. doi: 10.18632/oncotarget.6919.


Patient-derived xenograft (PDX) models are frequently used for translational cancer research, and are assumed to behave consistently as the tumor ages. However, growth rate constancy as a function of time is unclear. Notably, variable PDX growth rates over time might have implications for the interpretation of translational studies. We characterized four PDX models through several in vivo passages from primary human head and neck squamous cell carcinoma and salivary gland adenoid cystic carcinoma. We developed a mathematical approach to merge growth data from different passages into a single measure of relative tumor volume normalized to study initiation size. We analyzed log-relative tumor volume increase with linear mixed effect models. Two oral pathologists analyzed the PDX tissues to determine if histopathological feature changes occurred over in vivo passages. Tumor growth rate increased over time. This was determined by repeated measures linear regression statistical analysis in four different PDX models. A quadratic statistical model for the temporal effect predicted the log-relative tumor volume significantly better than a linear time effect model. We found a significant correlation between passage number and histopathological features of higher tumor grade. Our mathematical treatment of PDX data allows statistical analysis of tumor growth data over long periods of time, including over multiple passages. Non-linear tumor growth in our regression models revealed the exponential growth rate increased over time. The dynamic tumor growth rates correlated with quantifiable histopathological changes that related to passage number in multiple types of cancer.

Keywords: adenoid cystic carcinoma; head and neck squamous cell carcinoma; mathematical modeling; mouse models; tumor growth.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Adenoid Cystic / pathology*
  • Carcinoma, Squamous Cell / pathology*
  • Cell Adhesion
  • Cell Proliferation*
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Mice
  • Mice, SCID
  • Salivary Gland Neoplasms / pathology*
  • Time Factors
  • Tumor Burden
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays